Abstract Although immune checkpoint blockade (ICB) has achieved remarkable success in the treatment of cancer, numerous tumors, including breast cancer, demonstrate inherent or acquired resistance. Therefore, identifying novel immune checkpoints can enhance the advancement of supplementary immunotherapy approaches, aiming to enhance patient response.
Quan Chen
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Quan
Contact Quan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack